glp-1 news 2025 november 25 Weight-Loss Drug Demonstration Begins July 2026 Beyond Weight Loss: How GLP-1

But then again anticipating what's next is something we've been doing for 65 years

Made with natural ingredients to soothe and balance your gut, its the perfect companion for anyone using GLP-1 medications or looking to feel their best every day

Learn how to stay hydrated, signs of imbalance, and build a simple routine to support daily energy and balance.

Tirzepatide (Zepbound/Mounjaro): A dual GLP-1/GIP receptor agonist undergoing evaluation for MASH after demonstrating significant liver fat reduction in studies.Retatrutide: A "triple agonist" targeting GLP-1, GIP, and glucagon (GCGR) receptors, which has shown "unprecedented" efficacy in weight loss and is being evaluated for metabolic diseases including MASH